FDA Clearance Tracker · K183192
CapsoCam Plus (SV-3)
Last checked: Nov 19, 2026Latest source record: Apr 19, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Apr 19, 2019
Substantially Equivalent
Time to decision
151 days
Received Nov 19, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K183192
- Device name
- CapsoCam Plus (SV-3)
- Applicant
- CapsoVision, Inc.
- Applicant location
- Saratoga, CA
- Received
- Nov 19, 2018
- Decided
- Apr 19, 2019
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.1300
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NEZ. The earliest in FDA's data is DEN010002, decided Aug 1, 2001.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K183192
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for CapsoVision, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254230 · Decided Sep 25, 2026 · 270 days after receipt
Device type: Gastrointestinal Capsule Endoscopy Analysis Software Device (QZF) · GI, Urology & Nephrology
- CE Deliver (DLV)510(k)
K252480 · Decided Dec 19, 2025 · 134 days after receipt
Device type: System, Imaging, Gastrointestinal, Wireless, Capsule (NEZ) · GI, Urology & Nephrology
K242643 · Decided Dec 4, 2024 · 92 days after receipt
Device type: System, Imaging, Gastrointestinal, Wireless, Capsule (NEZ) · GI, Urology & Nephrology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.